Literature DB >> 956393

Adenosine metabolism in phytohemagglutinin-stimulated human lymphocytes.

F F Snyder, J Mendelsohn, J E Seegmiller.   

Abstract

The association of a human genetic deficiency of adenosine deaminase activity with combined immunodeficiency prompted a study of the effects of adenosine and of inhibition of adenosine deaminase activity on human lymphocyte transformation and a detailed study of adenosine metabolism throughout phytohemagglutinin-induced blastogenesis. The adenosine deaminase inhibitor, coformycin, at a concentration that inhibited adenosine deaminase activity more than 95%, or 50 muM adenosine, did not prevent blastogenesis by criteria of morphology or thymidine incorporation into acid-precipitable material. The combination of coformycin and adenosine, however, substantially reduced both the viable cell count and the incorporation of thymidine into DNA in phytohemagglutinin-stimulated lymphocytes. Incubation of lymphocytes with phytohemagglutinin for 72 h produced a 12-fold increase in the rate of deamination and a 6-fold increase in phosphorylation of adenosine by intact lymphocytes. There was no change in the apparent affinity for adenosine with either deamination or phosphorylation. The increased rates of metabolism, apparent as early as 3 h after addition of mitogen, may be due to increased entry of the nucleoside into stimulated lymphocytes. Increased adenosine metabolism was not due to changes in total enzyme activity; after 72 h in culture, the ratios of specific activities in extracts of stimulated to unstimulated lymphocytes were essentially unchanged for adenosine kinase, 0.92, and decreased for adenosine deaminase, 0.44. As much as 38% of the initial lymphocyte adenosine deaminase activity accumulated extracellularly after a 72-h culture with phytohemagglutinin. In phytohemagglutinin-stimulated lymphocytes, the principal route of adenosine metabolism was phosphorylation at less than 5 muM adenosine, and deamination at concentrations greater than 5 muM. In unstimulated lymphocytes, deamination was the principal route of adenosine metabolism over the range of adenosine concentrations studied (0.5-250 muM). These studies demonstrate the dependence of both the unstimulated and stimulated lymphocyte on adenosine and may account for the observed sensitivity of mitogen-stimulated lymphocytes to the toxic effects of exogenously supplied adenosine in the presence of the adenosine deaminase inhibitor coformycin. A single case of immunodeficiency disease has been reported in association with purine nucleoside phosphorylase deficiency. The catabolism of guanosine was also found to be enhanced in stimulated normal lymphocytes; phosphorolysis of guanosine to guanine by intact lymphocytes increased six fold after 72-h culture with phytohemagglutinin. The specific activity of purine nucleoside phosphorylase in extracts, with guanosine as substrate, was essentially the same in stimulated and unstimulated lymphocytes after 72 h of culture.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 956393      PMCID: PMC333224          DOI: 10.1172/JCI108512

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  SYNTHESIS OF 5-PHOSPHORIBOSYL 1-PYROPHOSPHATE FROM GLUCOSE IN EHRLICH ASCITES TUMOR CELLS IN VITRO.

Authors:  J F HENDERSON; M K KHOO
Journal:  J Biol Chem       Date:  1965-06       Impact factor: 5.157

2.  Adenosine deaminase activity in lymphoid cells during antibody production.

Authors:  J G HALL
Journal:  Aust J Exp Biol Med Sci       Date:  1963-02

3.  Serum adenosine deaminase: methodology and clinical applications.

Authors:  L H KOEHLER; E J BENZ
Journal:  Clin Chem       Date:  1962-04       Impact factor: 8.327

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Effects of adenosine nucleosides on adenylate cyclase, phosphodiesterase, cyclic adenosine monophosphate accumulation, and lipolysis in fat cells.

Authors:  J N Fain; R H Pointer; W F Ward
Journal:  J Biol Chem       Date:  1972-11-10       Impact factor: 5.157

6.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

7.  Evidence for control of several different tissue-specific isozymes of adenosine deaminase by a single genetic locus.

Authors:  R Hirschhorn; V Levytaka; B Pollara; H J Meuwissen
Journal:  Nat New Biol       Date:  1973-12-19

8.  On the mechanism of adenyl cyclase inhibition by adenosine.

Authors:  S G McKenzie; H P Bär
Journal:  Can J Physiol Pharmacol       Date:  1973-03       Impact factor: 2.273

9.  Mediated transport of nucleosides in human erythrocytes. Specific binding of the inhibitor nitrobenzylthioinosine to nucleoside transport sites in the erythrocyte membrane.

Authors:  C E Cass; L A Gaudette; A R Paterson
Journal:  Biochim Biophys Acta       Date:  1974-04-12

10.  Purine and pyrimidine pool sizes and purine base utilization in human lymphocytes and cultured lymphoblasts.

Authors:  T Fields; L Brox
Journal:  Can J Biochem       Date:  1974-06
View more
  28 in total

1.  The rate of the AMP/adenosine substrate cycle in concanavalin-A-stimulated rat lymphocytes.

Authors:  Z Szondy; E A Newsholme
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

2.  Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s).

Authors:  D A Carson; J Kaye; J E Seegmiller
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

Review 3.  Adenosine and adenosine receptors in immune function. Minireview and meeting report.

Authors:  R B Gilbertsen
Journal:  Agents Actions       Date:  1987-10

4.  Hypoxanthine-guanine phosphoribosyltransferase deficiency in three brothers with gout: characterization of a variant, HPRTEdinburgh, having altered isoelectric point, increased thermal lability and normal levels of messenger RNA.

Authors:  F F Snyder; J E Joyce; T Carter-Edwards; R Joshi; H L Rylance; R C Wallace; G Nuki
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

5.  Aerobic glycolysis and lymphocyte transformation.

Authors:  D A Hume; J L Radik; E Ferber; M J Weidemann
Journal:  Biochem J       Date:  1978-09-15       Impact factor: 3.857

6.  Adenosine release from stimulated mast cells.

Authors:  D L Marquardt; H E Gruber; S I Wasserman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

7.  Adenosine deaminase deficiency: disappearance of adenine deoxynucleotides from a patient's erythrocytes after successful marrow transplantation.

Authors:  S H Chen; H D Ochs; C R Scott; E R Giblett; A J Tingle
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

8.  Differential responses to mitogen stimulation in lymphocytes from normal individuals and Lesch-Nyhan patients: influence of the bicarbonate buffer system.

Authors:  P Gausset; E Vamos; G Delespesse; S Kulakowski; J Duchateau; C de Bruyn
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

9.  Altered purine and pyrimidine metabolism in erythrocytes with purine nucleoside phosphorylase deficiency.

Authors:  I H Fox; J Kaminska; N L Edwards; E Gelfand; K C Rich; W N Arnold
Journal:  Biochem Genet       Date:  1980-04       Impact factor: 1.890

10.  Action of deoxycoformycin on human T cell colonies in vitro.

Authors:  N R Colledge; A S Krajewski; J F Smyth; A H Wyllie
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.